KLDO - Kaleido Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KLDO is currently covered by 1 analysts

Kaleido Biosciences's activity chart (see below) currently has 15 price targets and 11 ratings on display. The stock rating distribution of KLDO is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40% with an average time for these price targets to be met of 35.4 days.

Highest price target for KLDO is $2, Lowest price target is $2.

Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 04-Apr-2022. First documented stock forecast 25-Mar-2019.

Best performing analysts who are covering KLDO - Kaleido Biosciences:

Matthew Harrison Keay Nakae Edward Tenthoff Jessica Fye Gobind Singh

Currently out of the existing stock ratings of KLDO, 1 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$1.7

$1.7 (0.00%)

$3

4 years 5 months 10 days ago
(04-Apr-2022)

0/3 (0%)

$0.06 (3.66%)

Buy

$4

$4 (0.00%)

$19

4 years 7 months 17 days ago
(28-Jan-2022)

0/2 (0%)

$2.26 (129.89%)

Buy

$22

$22 (0.00%)

$22

4 years 10 months 11 days ago
(03-Nov-2021)

0/2 (0%)

$14.82 (247.54%)

Sell

$3

$3 (0.00%)

$8

4 years 10 months 25 days ago
(20-Oct-2021)

6/6 (100%)

$-1.56 (-34.21%)

78

Sell

$5

$5 (0.00%)

$10

5 years 2 months 29 days ago
(16-Jun-2021)

2/2 (100%)

$-0.55 (-9.42%)

99

Show more analysts

Please expand the browser size to see the chart

What is KLDO (Kaleido Biosciences) average time for price targets to be met?

On average it took 35 days for the stock forecasts to be reached, with an average price target met ratio of 40%.

Which analyst most recently updated their price target on KLDO (Kaleido Biosciences)?

Keay Nakae

Which analyst has the current lower performing score on KLDO (Kaleido Biosciences) with a proven track record?

GOBIND SINGH

Which analyst has the most public recommendations on KLDO (Kaleido Biosciences)?

Keay Nakae works at CHARDAN CAPITAL and has 2 price targets and 7 ratings on KLDO

Which analyst is the currently most bullish on KLDO (Kaleido Biosciences)?

Gobind Singh with the highest potential upside of $22

Which analyst is the currently most reserved on KLDO (Kaleido Biosciences)?

Keay Nakae with the lowest potential downside of $1.7

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?